EATG » News

Testing Week Statement on Most Affected Populations – Read and Share

Anticipating the upcoming European HIV-Hepatitis Testing Week, an alliance of NGOs has issued the following statement in support of reaching out to and involving most affected populations in HIV and…

EATG signs on call to action for reconsidering primary HIV prevention

Reconsidering primary prevention: Call to action for the global HIV response The world needs a new phase in the evolution of the HIV response – one that reinvigorates prevention by…

ECHOES survey now LIVE: Community Health Workers are invited to provide input!

The ECHOES survey is now LIVE - Community Health Workers who provide sexual health and support services for MSM in the EU and neighbouring countries are invited to participate NOW…

EATG signs on joint statement from civil society organisations on the situation faced by the LGBTI community in Azerbaijan

Mass detention of Azeri LGBTI people– the LGBTI community urgently needs your support Alarming stories of physical violence, verbal abuse, forced medical examinations and detentions of LGBTI people have been…

Hepatitis prevention webinar – Register now!

EATG and the HAND - Hepatitis Access Needs Project would like to invite you to the upcoming webinar on Prevention of Hepatitis B and C that will take place on Monday, 16 October 2017,…

Register now! Webinar on hepatitis B treatment

EATG invites you to a community oriented webinar on Hepatitis B Treatment that will take place on Monday, 18 September 2017, 15:00 – 16:00 CET. The webinar will be held by…

EATG signs on submission to the European Commission on SPC review

Over 30 civil society organisations urge EU to abolish supplementary protection certificates mechanism In an open letter and open submission, thirty-three civil society organisations have called on the European Commission…

Register now! Webinar on regulatory approval of medicines

EATG invites you to a community oriented webinar on the Regulatory Approval Processes of Medicines that will take place on Wednesday, 13 September 2017, 15:00 – 16:00 CET. The webinar will be held…

Register now! Webinar on hepatitis C treatment

EATG invites you to a community oriented webinar on Hepatitis C Treatment that will take place on Tuesday, 12 September 2017, 15:00 – 16:00 CET. The webinar will be held by Prof.…

STEPS IV Cure Workshop in Milan on 24/10/2017

If you are planning to attend the EACS meeting in Milan, Italy (October 25-27), you are invited to apply to the fourth community meeting focused on HIV cure, therapeutic vaccines…

Conference invitation – From HIV testing and linkage to care to the integration of HIV, Hepatitis, TB & STIs

We are pleased to inform you about the European conference “from HIV testing and linkage to care to the integration of HIV, Hepatitis, TB & STIs” that will take place…

Community response to the drug-resistant TB crisis in Europe

On 12-15 May 2017, EATG, in collaboration with the Global TB Community Advisory Board (TB CAB), TBpeople (the Eastern European and Central Asian network of people with experience of TB)…

Register now! Webinar on hepatitis A in Europe

The World Health Organization reports that the recent outbreaks of hepatitis A virus (HAV) mainly affect communities of men having sex with men. We also know that people living with…

All EATG annual reports on one page

No more bulky printed booklets or large PDF files - view and read all EATG annual reports from the last four years on this page: https://www.eatgannualreport.com/ EATG has been working to…

EATG signed on TAG call for TB research for pregnant women

EATG signed a call initiated by Treatment Action Group (TAG, US) for support TB research for pregnant women that is addressed to the Task Force on Research Specific to Pregnant and…

New results from Flash! PrEP in Europe released at IAS 2017

Paris, 26 July: AIDES and PLUS announced to conference attendees from the world over results from the biggest European survey ever to be conducted regarding knowledge, interest and utilisation of…

IAS2017 – Community Paris Declaration published

At the IAS2017 Conference, Paris, 24/07/2017 It is international AIDS conferences that ignite minds and mark turning points in the fight against HIV. This is sometimes a scientific announcement (the arrival…

Lay Summaries workshop: Report now out!

Today the results from clinical trials are usually discussed within the scientific community only and are seldom spread to the general public. With the release of the EU Clinical Trials…

1st Interim Meeting for ESTICOM

EATG participated in the 1st Interim Meeting of the ESTICOM project (http://www.esticom.eu) in Brussels on 17-18/7. ESTICOM is, to some extent, the continuation and revision of the much-used and very useful…

EATG Project Management and Evaluation Webinars – All you need

EATG organised a series of webinars on the management, evaluation and monitoring of projects in advocacy. Hosted and presented by EATG member and social science researcher Ian Hodgson, the webinars…

New way to fight HIV transmission

Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection. The tool, a vaginal implant, decreases the number of cells that the HIV…

New way that HIV evades the immune system

Scientists have just discovered a new mechanism by which HIV evades the immune system, and which shows precisely how the virus avoids elimination. The new research shows that HIV targets…

HIV-infected people are living for years, but age-related diseases set in early

David Hardy has been treating HIV-infected patients since the early 1980s, when the epidemic began. In those days, people newly diagnosed with AIDS lived for only about six months. Hardy,…

Relationship between CD4 counts, hypertension in patients with HIV

With the more recent availability of highly active antiretroviral therapy (HAART), patients living with HIV/AIDS are living longer, healthier lives. This increase in life expectancy is also associated with an…

CROI 2018: Researchers puzzle over whether HIV accelerates cancer progression

Although people living with HIV may be diagnosed with cancer at an earlier stage because they get more consistent care than the general population, it is also possible that a…

Antiretroviral shortage reaches 100% in Venezuela

Every day, the media throughout Latin America show news about the situation in Venezuela, unsustainable wherever you look, and that affects the health and lives of thousands of people, including…

‘The earlier you go, the longer you live’: HIV self-testing in South Africa

In a country where people with HIV suffer hugely from discrimination, the privacy afforded by self-testing is having a positive impact on rates of diagnosis and treatment. David* is perched…

Treating hepatitis C and HIV coinfections in injecting drug users

In 2016, an estimated 2.3 million people living with HIV were coinfected with chronic hepatitis C virus (HCV). Of the coinfected population, more than half were intravenous drug users (IVDUs).…

Toward an effective strategy to combat HIV, hepatitis C and the opioid epidemic: Recommendations for policy makers

A dramatic increase in opioid use has led to drug-related overdose deaths surpassing motor vehicle accidents as the leading cause of mortality among adults under 50 in the U.S. In…

UN agency chief under pressure to quit over handling of sexual assault inquiry

Head of UNAids faces scrutiny after agency’s ‘deeply disturbing and tone-deaf’ response to allegations about former deputy The director of UNAids, Michel Sidibé, is facing calls to resign over his…

News from The International Liver Congress 2018

The International Liver Congress™ 2018 (ILC 2018) is taking place from 11-15 April 2018 in Paris, France. It is an annual congress, organized by The European Association for the Study…

ILC 2018: New affordable hepatitis C combination shows 97% cure rate

The combination of sofosbuvir and the new NS5A inhibitor ravidasvir cured 97% of people with hepatitis C in a study carried out in Malaysia, and could provide a safe and…

ILC 2018: EASL updates liver cancer guidelines

The European Association for the Study of the Liver (EASL) presented updated clinical practice guidelines for the management of hepatocellular carcinoma (HCC) during a special session at the 2018 International…

ILC 2018: Atea Pharmaceuticals reports positive proof of concept clinical data with AT-527 for the treatment of chronic hepatitis C

-- AT-527 is a novel pan-genotypic purine nucleotide prodrug NS5B polymerase inhibitor which has been safe and well tolerated in this ongoing multiple part trial -- AT-527 exhibits potent antiviral…

Sensitive new assay detects hepatitis B infection in single liver cells and serum

Technique measuring the cccDNA marker may allow earlier detection of hepatocellular carcinoma in patients, reports The Journal of Molecular Diagnostics Philadelphia, April 12, 2018 - Chronic hepatitis B virus (HBV)…

Ending hepatitis C means including people who inject drugs

With affordable, highly-effective hepatitis C (HCV) direct acting antiretroviral medications now available, innovative programs in San Francisco are reaching people who inject drugs with hepatitis C cure support and treatment.…

The UN’s internal struggle with drug policy

The UN General Assembly (GA) is responsible for passing the three main international drug conventions of 1961, 1971 and 1988 that shape modern drug policy. The UN bodies specifically dedicated…

Friends of the Global Fight releases new brief examining US leadership on HIV/AIDS, TB, malaria

Friends of the Global Fight: At the Tipping Point: U.S. Leadership to End AIDS, Tuberculosis and Malaria “…This forward-looking report asks: what is the end goal of America’s considerable investment…

EMA: Increasing oversight of API manufacturing through international collaboration

Report on the International API inspection programme published The European Medicines Agency (EMA) and its European and international partners have successfully strengthened their interactions to improve the oversight of active…

Eplerenone may improve inflammatory markers, but not insulin sensitivity in HIV

Insulin sensitivity and HbA1c were not substantially affected by treatment with eplerenone compared with placebo in adults with HIV; however, those assigned eplerenone saw improvements in HDL cholesterol, interleukin-6 and…